Keywords: انتشار ایزوپرن; BVOC; biogenic volatile organic compound; GGDP; geranylgeranyl diphosphate; GLM; generalized linear model; GLV; green leaf volatiles; LOX; lipoxygenase pathway; MEP/DOXP pathway; 2-C-methyl-d-erythritol 4-phosphate/1-deoxy-d-xylulose 5-phosphate pathway;